Immediately prior to joining Cutera, Gardiner served as vice president, finance and chief financial officer with Tria Beauty, Inc., a medical device manufacturer of laser-based aesthetic devices. Gardiner joined Tria Beauty last April 2015, until its acquisition last April. Gardiner has over 27 years of experience in the life science industry with 19 years specifically in the medical device industry. In addition to Tria Beauty, Gardiner has been chief financial officer of two publically traded entities, Vermillion and Lipid Sciences, as well as three privately held companies: Asante Solutions, Aptus Endosystems and Ventus Medical. Gardiner holds a Bachelor of Arts degree in management economics from the University of California, Davis and began her career with advanced cardiovascular systems. 
"We’re delighted to welcome Sandy to this permanent role at Cutera and to our executive leadership team as our CFO,” said James Reinstein, Cutera’s CEO. “Sandy is equipped with a strong healthcare and device background, coupled with the financial acumen and acuity to manage our financial strategy. In her short time in the consulting CFO position, she’s made incredible progress, and had a significant impact on scaling our finance organization for Cutera’s future.  I previously worked with Sandy and know she will help drive performance, expand our portfolio, and manage our financial architecture in a sustainable manner.”
“I am thrilled to join the exceptional team at Cutera on a permanent basis,” said Gardiner. “In the short time I’ve been associated with the team at Cutera, it’s clear we share a passion [for] innovative products, while focusing on growth that will lead us to even greater success as a company.”